Real-time enrollment status for this covid-19 clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:01 PM UTC
| NCT Number | NCT06667700 |
| Recruiting Status | Recruiting |
| Condition | COVID-19 |
| Phase | PHASE3 |
| Target Enrollment | 3,082 participants |
| Active Locations | 71 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06667700 is currently recruiting participants. This phase3 study for covid-19 is actively seeking new participants at 71 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06667700 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 71 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06667700 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.